{"filings":[{"id":649799,"accession_number":"0001193125-26-237916","cik":1921865,"company_name":"ASP Isotopes Inc.","ticker":"ASPI","form_type":"8-K","filed_at":"2026-05-26T12:01:15+00:00","items":["7.01","9.01"],"status":"ready","headline":"ASP Isotopes restarts first 18 stages of Si-28 enrichment; expects Q3 2026 commercial shipments","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Announced successful restart of first 18 stages of Silicon-28 enrichment facility in Pretoria, South Africa.","Three commercial contracts signed with U.S. customers for enriched Silicon-28 for quantum computing and semiconductors.","Initial commercial shipments of enriched Silicon-28 expected to commence in Q3 2026.","Engineering modifications over nine months addressed non-core components (valves, compressors, piping).","First samples shipped to U.S. customer in August 2025; independent analysis confirmed enrichment targets."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":968826999.8725638,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":556758,"accession_number":"0001193125-26-232841","cik":1921865,"company_name":"ASP Isotopes Inc.","ticker":"ASPI","form_type":"8-K","filed_at":"2026-05-20T21:15:15+00:00","items":["7.01"],"status":"ready","headline":"ASP Isotopes posts updated investor presentation; no specific financial data disclosed","summary_kind":"llm","event_type":"other_material","confidence":"low","bullets":["Presentation posted on company website on May 20, 2026.","No material new financial or operational data provided in the 8-K.","Presentation includes forward-looking statements and safe harbor language."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":968826999.8725638,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":96751,"accession_number":"0001193125-26-215717","cik":1921865,"company_name":"ASP Isotopes Inc.","ticker":"ASPI","form_type":"8-K","filed_at":"2026-05-11T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"ASPI subsidiary QLE signs MOU to supply HALEU to European reactor developer","summary_kind":"llm","event_type":"other_material","confidence":"medium","bullets":["Non-binding MOU between QLE (ASPI subsidiary) and a European nuclear technology company for HALEU supply.","Partner to provide uranium feedstocks; QLE to enrich and produce HALEU (U-235 >10%) for delivery.","Potential HALEU deliveries begin in 2028, scaling through 2036 based on partner's reactor timeline.","MOU term through December 31, 2030; includes technical and economic assessment of collaboration.","Collaboration aims to address critical need for diverse, reliable HALEU production for advanced reactors."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":968826999.8725638,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":96750,"accession_number":"0001193125-26-207578","cik":1921865,"company_name":"ASP Isotopes Inc.","ticker":"ASPI","form_type":"8-K","filed_at":"2026-05-06T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"ASP Isotopes subsidiary QLE appoints Dr. Peter Fiske to Strategic Advisory Board","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Dr. Fiske is founding Executive Director of DOE's $110M NAWI energy-water innovation hub at Lawrence Berkeley Lab.","QLE is ASPI's wholly-owned subsidiary focused on fission and fusion nuclear fuel cycle technologies.","Appointment follows QLE's recent formation of SAB, CTO Nate Salpeter hire, and Univ. of Bristol lithium laser facility collaboration.","Dr. Fiske's role will advise on government partnerships and advanced materials strategy for QLE."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":968826999.8725638,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":96749,"accession_number":"0001477932-26-002140","cik":1921865,"company_name":"ASP Isotopes Inc.","ticker":"ASPI","form_type":"8-K","filed_at":"2026-04-13T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"ASP Isotopes targets first commercial shipments in 2026 and >$300M EBITDA by 2031","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["First commercial shipments of Silicon-28, Carbon-14, and Ytterbium-176 expected in Q2–Q3 2026.","Helium Phase 1 nameplate capacity of 58 MCF/day liquid helium expected by Q3 2026.","Cash, equivalents, and marketable securities totaled $333M as of Dec 31, 2025.","Acquired two U.S. radiopharmacies (Florida Oct 2025, South Carolina) for radiopharmaceutical expansion.","QLE submitted draft S-1 for public listing and signed MOU with large U.S. energy company for enriched uranium."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":968826999.8725638,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":96748,"accession_number":"0001477932-26-002103","cik":1921865,"company_name":"ASP Isotopes Inc.","ticker":"ASPI","form_type":"8-K","filed_at":"2026-04-10T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"ASP Isotopes schedules business update call for April 13, 2026 at 8:00 AM ET","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["CEO Paul Mann will host the call; dial-in +1.646.968.2525 (conference ID 5073116).","Webcast available at events.q4inc.com/attendee/430022486; replay at aspisotopes.com after 3 hours.","No financial results or material developments disclosed in the press release."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"market_cap_usd":968826999.8725638,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":110947,"accession_number":"0001477932-26-001545","cik":1921865,"company_name":"ASP Isotopes Inc.","ticker":"ASPI","form_type":"8-K","filed_at":"2026-03-24T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"ASP Isotopes subsidiary QLE partners with University of Bristol on lithium laser research facility design","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["UK subsidiary of Quantum Leap Energy (QLE) and University of Bristol to design a lithium laser enrichment research facility.","University of Bristol leads four-month design and feasibility study; intent to build off-campus site if positive.","QLE's UK program developed with input from UK Dept. for Energy Security, UK Atomic Energy Authority, and regulators.","Enriched lithium-6 (60-90%) is critical for fusion reactor breeding systems; QE technology aims to redefine nuclear fuel supply.","This collaboration advances ASP Isotopes' strategy to meet growing demand for advanced nuclear fuels."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":968826999.8725638,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":110935,"accession_number":"0001477932-26-001559","cik":1921865,"company_name":"ASP Isotopes Inc.","ticker":"ASPI","form_type":"8-K/A","filed_at":"2026-03-24T23:59:59+00:00","items":["9.01"],"status":"ready","headline":"ASP Isotopes files Renergen financials and pro forma; risk factors highlight Phase 2 obstacles","summary_kind":"llm","event_type":"m_and_a","confidence":"medium","bullets":["Filed Renergen unaudited financials for six months ended Aug 31, 2025, and pro forma combined data for periods ended Sep 30, 2025 and Aug 31, 2025, and year ended Dec 31, 2024/Feb 28, 2025.","Risk factors detail Phase 2 expansion risks: cost overruns, permitting delays, potential inability to obtain required licenses.","Conditional DFC approval for up to $500M senior secured debt and Standard Bank $250M for Phase 2, subject to conditions including 90% land rights and offtake covering 50% of debt service.","Warns of dependence on customer adoption of LNG as diesel substitute and limited customer base for take-or-pay contracts.","No assurance of obtaining financing for Phase 2 on acceptable terms, if at all, due to numerous conditions precedent."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":968826999.8725638,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":110946,"accession_number":"0001477932-26-001524","cik":1921865,"company_name":"ASP Isotopes Inc.","ticker":"ASPI","form_type":"8-K","filed_at":"2026-03-23T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"ASP Isotopes completes Phase 1 drilling for Renergen Helium Project 4 months early; cites Qatar supply disruption","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Completed well drilling for Phase 1 of Renergen Helium Project in South Africa, four months ahead of schedule.","Gas flow rates up to 16 times higher than earlier wells; reservoir meets or exceeds estimated type curves.","Phase 1 expected to produce 58 MCF/day liquid helium and 2,500 GJ/day LNG by end of 2026.","Qatar helium supply disrupted by Strait of Hormuz closure and Ras Laffan damage; company expects upward pricing pressure.","Phase 2 planning to commence after Phase 1, targeting 895 MCF/day helium and 34,000 GJ/day LNG within 44 months."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":968826999.8725638,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":110945,"accession_number":"0001477932-26-001256","cik":1921865,"company_name":"ASP Isotopes Inc.","ticker":"ASPI","form_type":"8-K","filed_at":"2026-03-10T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"ASP Isotopes to present at Canaccord Genuity Virtual Sustainability Summit on March 12","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["CEO Paul Mann will participate in a fireside chat at the Summit on Thursday, March 12, 2026 at 3:20 p.m. ET.","Live audio webcast available in Investors section of the Company's website.","A replay of the webcast will be available within 48 hours after the event."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"market_cap_usd":968826999.8725638,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":110944,"accession_number":"0001477932-26-001216","cik":1921865,"company_name":"ASP Isotopes Inc.","ticker":"ASPI","form_type":"8-K","filed_at":"2026-03-06T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"ASP Isotopes' subsidiary QLE signs MOU with major U.S. energy co. for nuclear fuel supply chain","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Quantum Leap Energy (ASPI subsidiary) signs non-binding MOU with large U.S. energy company.","MOU covers evaluation of support for U.S. facilities producing HALEU and LEU+, plus conversion services.","Aims to strengthen domestic enriched uranium supply amid 2028 Russian import ban.","QLE expects HALEU to fuel advanced reactors and LEU+ to boost existing reactor output.","CEO Ryno Pretorius says MOU is important step toward establishing domestic supply chain."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":968826999.8725638,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":110943,"accession_number":"0001477932-26-001176","cik":1921865,"company_name":"ASP Isotopes Inc.","ticker":"ASPI","form_type":"8-K","filed_at":"2026-03-05T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"ASP Isotopes subsidiary Quantum Leap Energy names Dr. Nate Salpeter as CTO","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Dr. Nate Salpeter appointed CTO of Quantum Leap Energy, ASP Isotopes' subsidiary.","Salpeter previously first fluid dynamicist at TerraPower and Kairos Power; 15+ years experience.","Responsibilities include optimizing technologies, leading de-risking, and building computational/experimental frameworks.","Salpeter co-founded deep-tech fund SNØCAP and non-profit Sweet Farm Foundation; holds Ph.D. in Mechanical Engineering.","CEO Ryno Pretorius: 'Salpeter's appointment marks a significant milestone in the Company's growth.'"],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":968826999.8725638,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":110942,"accession_number":"0001477932-26-000963","cik":1921865,"company_name":"ASP Isotopes Inc.","ticker":"ASPI","form_type":"8-K","filed_at":"2026-02-23T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"ASP Isotopes subsidiary signs pre-implementation contract with Necsa for HALEU enrichment","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Contract executed Feb 20, 2026 between QLE SA (ASPI subsidiary) and Necsa for enrichment facility at Pelindaba.","Goal: achieve market readiness for HALEU production to supply next-generation nuclear reactors.","Joint Coordination Committee formed with two representatives from each party to oversee implementation.","DOE estimates US HALEU demand of 50 metric tons/year by 2035, rising to 500 mt/year by 2050.","QLE CEO Ryno Pretorius and Necsa CEO Loyiso Tyabashe cited the partnership as critical for HALEU supply."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":968826999.8725638,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":110941,"accession_number":"0001477932-26-000899","cik":1921865,"company_name":"ASP Isotopes Inc.","ticker":"ASPI","form_type":"8-K","filed_at":"2026-02-19T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"ASPI subsidiary QLE establishes Strategic Advisory Board, appoints Dunzik-Gougar and Kramer","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Quantum Leap Energy (QLE), wholly-owned subsidiary of ASP Isotopes, formed a Strategic Advisory Board to guide nuclear fuel cycle initiatives.","Initial SAB members: Mary Lou Dunzik-Gougar (nuclear engineering professor, former ANS president) and Kevin Kramer (business development expert, ex-ATI and Alcoa).","QLE plans to leverage ASP Isotopes' ASP and QE isotope separation technologies for nuclear fuel products.","The SAB aims to accelerate market entry and strengthen partnerships in fission and fusion fuel sectors."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":968826999.8725638,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":110940,"accession_number":"0001477932-26-000834","cik":1921865,"company_name":"ASP Isotopes Inc.","ticker":"ASPI","form_type":"8-K","filed_at":"2026-02-17T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"ASP Isotopes subsidiary Quantum Leap Energy to establish HQ in Austin, TX; plans HALEU facility with Fermi America","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["QLE, wholly owned by ASPI, will set up global headquarters in Austin, Texas, citing the state's pro-nuclear stance.","QLE intends to build a significant operational presence in Texas, including a HALEU enrichment facility.","Joint venture with Fermi America targets development of a HALEU enrichment research and commercial production facility in Amarillo.","Texas Governor Greg Abbott welcomed QLE's headquarters, supporting nuclear resurgence.","US DOE estimates HALEU demand of 50 metric tons/year by 2035 and 500 metric tons/year by 2050."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":968826999.8725638,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":110939,"accession_number":"0001477932-26-000555","cik":1921865,"company_name":"ASP Isotopes Inc.","ticker":"ASPI","form_type":"8-K","filed_at":"2026-01-30T23:59:59+00:00","items":["1.01"],"status":"ready","headline":"ASP Isotopes invests ~$10M in Opeongo, gets right of first offer on medical isotope supply","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Purchased 4,356,918 Series Seed-1 Preferred shares of Opeongo at $2.2952 per share (approx $10M investment).","Opeongo is a biotech developing ECM modulators for fibrosis, inflammation, and cancer; co-founded by David Baram and Irit Sagi.","ASPI secures right of first offer to supply medical isotopes for any Opeongo pharmaceutical product (supply agreement to be negotiated).","Related party: ASPI CEO Paul Mann designated as Series Seed-1 Director of Opeongo; CMO Todd Wider also a director."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":968826999.8725638,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":110938,"accession_number":"0001477932-26-000494","cik":1921865,"company_name":"ASP Isotopes Inc.","ticker":"ASPI","form_type":"8-K","filed_at":"2026-01-29T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"ASP Isotopes reports 80% drilling success, 60% gas throughput increase at Renergen Helium Project","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["15 of 18 wells hit gas (80% success) post-restart; Kinley Exploration engaged for reservoir modeling.","Gas throughput up ~60% vs pre-April 2025; plant upgrades including compressor and dewar filling system.","~60% of Phase 1 LNG offtake contracted; initial helium supply agreements in place.","Project on track for positive operational cash flow before end of 2026.","New shallow sandstone reservoir (<400m) with confirmed gas shows not in prior reserve estimates."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":968826999.8725638,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":110937,"accession_number":"0001477932-26-000162","cik":1921865,"company_name":"ASP Isotopes Inc.","ticker":"ASPI","form_type":"8-K","filed_at":"2026-01-12T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"ASP Isotopes appoints Renergen's CEO Marani as President, COO Mitchell as Co-COO after deal close","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Stefano Marani appointed President, Electronics and Space; Nick Mitchell appointed Co-Chief Operating Officer, effective Jan 6, 2026.","Marani base salary $550K/yr, Mitchell $400K/yr; each eligible for 50% annual bonus in cash and stock.","Each received 700,000 restricted shares vesting in eight equal 87,500-share installments every six months over four years.","Appointments follow closing of previously announced acquisition of Renergen Limited."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":968826999.8725638,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":110936,"accession_number":"0001477932-26-000055","cik":1921865,"company_name":"ASP Isotopes Inc.","ticker":"ASPI","form_type":"8-K","filed_at":"2026-01-07T23:59:59+00:00","items":["2.01","3.02","8.01","9.01"],"status":"ready","headline":"ASP Isotopes closes acquisition of Renergen; issues 14.27M shares; new execs appointed","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Acquired all Renergen shares via scheme of arrangement; exchange ratio 0.09196 ASPI share per Renergen share.","Issued 14,270,000 shares; Renergen becomes wholly owned subsidiary; delisted from JSE, ASX, A2X.","Combined company targets helium and isotopes; Renergen's Virginia Gas project has $40M US DFC funding plus expected $500M DFC and $250M Standard Bank debt facilities.","Renergen CEO Stefano Marani appointed President, Electronics and Space; COO Nick Mitchell appointed Co-COO.","Inducement grants of 700,000 restricted shares each to Marani and Mitchell, vesting over four years."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":968826999.8725638,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":127576,"accession_number":"0001477932-25-009061","cik":1921865,"company_name":"ASP Isotopes Inc.","ticker":"ASPI","form_type":"8-K","filed_at":"2025-12-19T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"ASP Isotopes announces results of 2025 Annual Meeting; elects two Class III directors","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Shareholders elected Sipho N. Maseko (40.6M for, 315K withheld) and Todd Wider (24.1M for, 16.8M withheld).","Ratified EisnerAmper as independent auditor for FY2025 with 68.6M for, 442K against, 1.1M abstentions.","Broker non-votes on director elections totaled 29.3M shares not voted."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"market_cap_usd":968826999.8725638,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":127575,"accession_number":"0001477932-25-009035","cik":1921865,"company_name":"ASP Isotopes Inc.","ticker":"ASPI","form_type":"8-K","filed_at":"2025-12-18T23:59:59+00:00","items":["7.01"],"status":"ready","headline":"ASP Isotopes receives compliance certificate for Renergen scheme; implementation timeline set","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["South African Takeover Panel issued compliance certificate for scheme to acquire Renergen Ltd.","Renergen shareholders will receive 0.09196 new ASP Isotopes shares per Renergen share held.","JSE last trading date for Renergen shares is Dec 29, 2025; Scheme Implementation Date is Jan 6, 2026.","Renergen share listing on JSE, A2X, and ASX to terminate on or about Jan 12, 2026.","Cross-border settlement details provided for South African and Australian register participants."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":968826999.8725638,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":127574,"accession_number":"0001477932-25-009004","cik":1921865,"company_name":"ASP Isotopes Inc.","ticker":"ASPI","form_type":"8-K","filed_at":"2025-12-17T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"ASP Isotopes receives all regulatory approvals for Renergen acquisition; scheme unconditional","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["All regulatory approvals obtained for acquisition of Renergen via scheme of arrangement under South African law.","Renergen shareholders will receive 0.09196 new ASP Isotopes shares per Renergen share held.","Compliance certificate from SA Takeover Regulation Panel expected on/about Dec 18, 2025.","Positive progress at Renergen's Virginia Gas Project; production update expected end of Jan 2026.","Combination aims to create global leader in critical materials, including helium and isotopically enriched gases."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":968826999.8725638,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":127573,"accession_number":"0001477932-25-008843","cik":1921865,"company_name":"ASP Isotopes Inc.","ticker":"ASPI","form_type":"8-K","filed_at":"2025-12-08T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Paul Mann to resume CEO role at ASP Isotopes on Jan 19, 2026; Ainscow returns to COO","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Founder/Exec Chairman Paul Mann reassumes CEO role effective Jan 19, 2026, after medical leave.","Interim CEO Robert Ainscow will continue as COO; no new compensatory arrangements disclosed.","The transition is a planned succession; no agreement with any other person for Mann's appointment.","Mann's biographical info is incorporated from the Nov 25, 2025 proxy statement."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":968826999.8725638,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":127572,"accession_number":"0001477932-25-008735","cik":1921865,"company_name":"ASP Isotopes Inc.","ticker":"ASPI","form_type":"8-K","filed_at":"2025-12-03T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"ASP Isotopes founder Paul Mann to return as CEO on Jan 19, 2026 after health leave","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Paul Mann resumes CEO role effective Jan 19, 2026; continues as Executive Chairman.","Interim CEO Robert Ainscow returns to COO position; Mann thanks him for leading during leave.","Mann took temporary leave on Sep 29, 2025 for health reasons; now able to travel again.","Mann states 2026 potential to be 'highly transformative' with strengthened execution frameworks."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":968826999.8725638,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":127571,"accession_number":"0001477932-25-008651","cik":1921865,"company_name":"ASP Isotopes Inc.","ticker":"ASPI","form_type":"8-K","filed_at":"2025-11-28T23:59:59+00:00","items":["1.01","8.01","9.01"],"status":"ready","headline":"ASP Isotopes extends Renergen acquisition deadline to Jan 30, 2026; awaits FinSurv approval","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Longstop date for Renergen acquisition extended to Jan 30, 2026 to allow time for remaining regulatory conditions.","Remaining key condition: approval from the South African Reserve Bank's Financial Surveillance Department (FinSurv).","Previously received approvals: Competition Commission, Industrial Development Corporation of South Africa, and U.S. International Development Finance Corporation.","ASPI also extended the loan repayment date from Renergen under the Term Loan Facility Agreement to Jan 30, 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":968826999.8725638,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":127570,"accession_number":"0001477932-25-008541","cik":1921865,"company_name":"ASP Isotopes Inc.","ticker":"ASPI","form_type":"8-K","filed_at":"2025-11-21T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"ASP Isotopes releases Q3 2025 business update presentation without specific financial figures","summary_kind":"llm","event_type":"other","confidence":"low","bullets":["Filed an 8-K on Nov 21, 2025 attaching a presentation for its quarterly business update conference.","Presentation includes forward-looking statements and is provided under Regulation FD.","No specific financial results, operational metrics, or guidance changes were disclosed in the filing text.","The presentation is dated November 2025 and the company disclaims any obligation to update it."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"market_cap_usd":968826999.8725638,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":127569,"accession_number":"0001477932-25-008410","cik":1921865,"company_name":"ASP Isotopes Inc.","ticker":"ASPI","form_type":"8-K","filed_at":"2025-11-17T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"ASP Isotopes schedules quarterly business update call for Nov 21, 2025","summary_kind":"llm","event_type":"other","confidence":"medium","bullets":["Call on Friday, Nov 21, 2025 at 8:30 a.m. Eastern Time.","Dial-in: USA/Intl Toll +1.646.968.2525; USA Toll-Free +1.888.596.4144; Conference ID 5073116.","Webcast link: https://events.q4inc.com/attendee/428149635.","Transcript to be posted on ASPI website after call."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.05,"calibrated_materiality_score":0.05,"market_cap_usd":968826999.8725638,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":127568,"accession_number":"0001477932-25-008327","cik":1921865,"company_name":"ASP Isotopes Inc.","ticker":"ASPI","form_type":"8-K","filed_at":"2025-11-14T23:59:59+00:00","items":["1.01","2.03","3.02","9.01"],"status":"ready","headline":"ASP Isotopes subsidiary QLE raises ~$64.3M via convertible notes at 8% interest, existing 2024 notes auto-convert","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["QLE issued ~$64.3M in 8% convertible notes due Nov 2030; proceeds for laser enrichment facilities.","Existing March & June 2024 QLE convertible notes (~$147.7M principal) auto-convert into new notes.","ASPI is not a guarantor; notes are unsecured and subordinate to bank debt, with no prepayment allowed.","Conversion triggers include IPO/SPAC/direct listing (80% discount), Next Equity Financing ($20M+), or change of control (1.5x principal).","Valuation cap is $400M plus offering proceeds; Canaccord Genuity and Ocean Wall acted as placement agents (6% commission)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":968826999.8725638,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":127567,"accession_number":"0001477932-25-008096","cik":1921865,"company_name":"ASP Isotopes Inc.","ticker":"ASPI","form_type":"8-K","filed_at":"2025-11-12T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"ASP Isotopes subsidiary QLE confidentially files draft S-1 for proposed IPO","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Quantum Leap Energy LLC (wholly-owned subsidiary) submitted draft Form S-1 to SEC for IPO of Class A common stock.","Number of shares and price range not yet determined; offering subject to SEC review and market conditions.","ASP Isotopes expects to use net proceeds for investments, reduce borrowings, and repay indebtedness.","No specific allocation of proceeds; syndicated DSTs, land, and development will be less than 20% of portfolio total value.","Sealy Investment Services to serve as managing broker-dealer on best-efforts basis, earning up to 2.5% of aggregate purchase price."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":968826999.8725638,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":127566,"accession_number":"0001477932-25-007963","cik":1921865,"company_name":"ASP Isotopes Inc.","ticker":"ASPI","form_type":"8-K","filed_at":"2025-11-07T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"QLE subsidiary raises $64.3M via convertible notes; Eric Trump, Donald Trump Jr. invest","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Initial closing of $64.3M aggregate principal amount of QLE convertible notes, led by American Ventures LLC.","ASPI also invested; Eric Trump and Donald Trump Jr. contributed capital.","Notes unsecured, convertible into QLE equity at 80% of future equity price or valuation cap; 5-year maturity.","Proceeds to build laser enrichment production facilities; prior 2024 convertible notes automatically converted.","Closing expected on/about Nov 10, 2025, subject to customary conditions."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":968826999.8725638,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":127565,"accession_number":"0001477932-25-007913","cik":1921865,"company_name":"ASP Isotopes Inc.","ticker":"ASPI","form_type":"8-K","filed_at":"2025-11-05T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"ASP Isotopes UK unit begins regulatory engagement for HALEU production; hires Rich Deakin","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Quantum Leap Energy Ltd (QLE) starts early engagement with UK Office for Nuclear Regulation (ONR).","UK Dept for Energy Security and Net Zero (DESNZ) confirmed QLE's eligibility for nuclear regulatory pathway.","Aims to become first commercial HALEU producer in UK; full licensing possible within this decade.","Rich Deakin appointed SVP & Managing Director UK Strategic Projects; 35+ years nuclear experience.","QLE preparing nuclear site licence and environmental permit applications; site selection underway."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":968826999.8725638,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":127564,"accession_number":"0001477932-25-007716","cik":1921865,"company_name":"ASP Isotopes Inc.","ticker":"ASPI","form_type":"8-K","filed_at":"2025-10-23T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"ASP Isotopes subsidiary Quantum Leap Energy acquires One 30 Seven assets for nuclear waste processing","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Acquired substantially all assets of One 30 Seven Inc. for $150k cash and 266,113 ASPI shares (~$2.85M).","Earnout potential: $6M on validated Creber Mini Unit and up to $11M on Midi/Maxi Unit.","Consulting agreement with B-Con Engineering for $4.5M over 18 months to develop Creber Mini, then $12.5-13M for larger units.","Technology aims to accelerate beta decay of high-level waste (Cesium-137, Strontium-90) to reduce DOE $44.5B liability.","Global nuclear waste: 390,000 metric tons, 90,000 in US; technology could convert HLW to stable isotopes."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":968826999.8725638,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":127563,"accession_number":"0001477932-25-007607","cik":1921865,"company_name":"ASP Isotopes Inc.","ticker":"ASPI","form_type":"8-K","filed_at":"2025-10-16T23:59:59+00:00","items":["1.01","8.01","9.01"],"status":"ready","headline":"ASP Isotopes prices 17.2M share offering at $11.65 for $210.3M gross proceeds","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Offering of 17,167,380 shares at $11.65 each; gross proceeds ~$210.3M before expenses.","Underwriters granted option to purchase up to an additional 2,575,106 shares (~$31.5M) at same price.","Last closing price prior to pricing was $14.05; offering represents a ~17% discount.","Expected to close October 16, 2025; net proceeds for general corporate purposes including working capital and capex.","Cantor Fitzgerald & Co. and Lucid Capital Markets, LLC acted as joint book-running managers."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":968826999.8725638,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":127562,"accession_number":"0001477932-25-007513","cik":1921865,"company_name":"ASP Isotopes Inc.","ticker":"ASPI","form_type":"8-K","filed_at":"2025-10-14T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"ASP Isotopes signs largest silicon-28 supply contract; acquires Florida radiopharmacy","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Entered supply contract for enriched silicon-28 with U.S. customer, largest to date; deliveries expected Q1 2026.","Acquired an independent radiopharmacy in Florida, first U.S. expansion for PET Labs; expected accretive to 2026 revenues, EBITDA and EPS.","PET Labs also signed non-binding term sheet for another U.S. acquisition and is in discussions for additional radiopharmacies.","Granted 30,000 restricted shares as inducement award to new non-executive employee at Quantum Leap Energy; vests in eight semi-annual installments."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":968826999.8725638,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":127561,"accession_number":"0001477932-25-007343","cik":1921865,"company_name":"ASP Isotopes Inc.","ticker":"ASPI","form_type":"8-K","filed_at":"2025-10-03T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"CEO Paul Mann steps down for health reasons; COO Robert Ainscow named Interim CEO","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Effective Oct 1, 2025, Paul Mann becomes Executive Chairman; takes temporary CEO leave for health reasons.","Robert Ainscow, previously COO, appointed Interim CEO (principal executive officer) effective Oct 1.","Donald Ainscow (Robert's brother) is EVP, General Counsel & Secretary with base salary $425k/year + equity.","No new compensatory arrangements entered into with Robert Ainscow in connection with Interim CEO role."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":968826999.8725638,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":144358,"accession_number":"0001477932-25-007195","cik":1921865,"company_name":"ASP Isotopes Inc.","ticker":"ASPI","form_type":"8-K","filed_at":"2025-09-30T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"ASP Isotopes receives purchase order for enriched Barium-137; delivery Q1 2026","summary_kind":"llm","event_type":"other_material","confidence":"medium","bullets":["Purchase order from a US-based customer for enriched Barium-137, with delivery scheduled during Q1 2026.","Barium-137 is a critical enabler for ion-trap quantum computing, offering stable qubit platform and visible-light operation.","CEO states order is key step to become leading supplier of advanced materials to the quantum computing industry.","CCO says order aligns with multi-isotope electronic gases strategy serving quantum, semiconductors, AI markets.","Financial terms and volume of the purchase order were not disclosed."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.45,"calibrated_materiality_score":0.45,"market_cap_usd":968826999.8725638,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":144357,"accession_number":"0001477932-25-007115","cik":1921865,"company_name":"ASP Isotopes Inc.","ticker":"ASPI","form_type":"8-K","filed_at":"2025-09-29T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"CEO Paul Mann steps down to Executive Chairman on health leave; COO Ainscow named Interim CEO","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Paul Mann becomes Executive Chairman, taking temporary leave from CEO duties for health reasons (orthopedic surgery recovery may take several months).","Robert Ainscow, COO and co-founder, appointed Interim CEO effective Oct 1, 2025, while remaining COO.","Michael Cunniffe appointed CFO of subsidiary Quantum Leap Energy LLC, effective Oct 1; Heather Kiessling remains ASP Isotopes CFO.","Company plans investor tour in South Africa Nov 12-13, 2025, and first quarterly business update webinar in Nov 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":968826999.8725638,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":144356,"accession_number":"0001477932-25-006900","cik":1921865,"company_name":"ASP Isotopes Inc.","ticker":"ASPI","form_type":"8-K","filed_at":"2025-09-22T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"ASP Isotopes subsidiary QLE acquires 79% voting control of Skyline Builders (SKBL) for $1M","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["QLE bought 1,995,000 Class B shares from Supreme Development for $1M; each carries 20 votes.","SKBL closed $17.8M private placement; QLE purchased $1.5M in shares and warrants.","CEO Paul Mann invested $2.5M individually in the private placement.","$7M of proceeds used to retire 18.5M Class A shares from former controlling shareholder.","Post-transaction, QLE holds 79.14% of aggregate voting power of SKBL."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":968826999.8725638,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":144355,"accession_number":"0001477932-25-006736","cik":1921865,"company_name":"ASP Isotopes Inc.","ticker":"ASPI","form_type":"8-K","filed_at":"2025-09-15T23:59:59+00:00","items":["7.01"],"status":"ready","headline":"ASP Isotopes extends longstop date for Renergen acquisition to Nov 28, 2025","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Longstop date for Renergen scheme of arrangement extended from Sep 30 to Nov 28, 2025.","Extension allows more time to secure outstanding regulatory approval from South African Reserve Bank (FinSurv).","Deal terms unchanged: Renergen shareholders receive 0.09196 ASPI shares per share held.","Company and Renergen continue pursuing timely FinSurv approval and third-party consents."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":968826999.8725638,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":144354,"accession_number":"0001477932-25-006556","cik":1921865,"company_name":"ASP Isotopes Inc.","ticker":"ASPI","form_type":"8-K","filed_at":"2025-09-08T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"ASPI expands board to seven, elects Ralph L. Hunter as Class II director","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Board increased to seven members; Hunter elected effective Sept. 8, 2025, as Class II director with term through 2027 annual meeting.","Hunter also appointed to board of managers of subsidiary Quantum Leap Energy LLC.","Hunter awarded 10,470 shares of restricted stock vesting on one-year anniversary of grant.","Hunter has 35+ years in nuclear power including roles at Orion Nuclear and Constellation Energy."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":968826999.8725638,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":144353,"accession_number":"0001477932-25-006452","cik":1921865,"company_name":"ASP Isotopes Inc.","ticker":"ASPI","form_type":"8-K","filed_at":"2025-09-02T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"ASP Isotopes ships first isotope samples, eyes $50-70M revenue, Renergen merger on track","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Shipped first samples of Ytterbium-176 and Silicon-28; expects $50-70M revenue from these in 2026-2027.","Started procurement for four new laser plants for Gadolinium-160, Zinc-68, Nickel-64, Lithium-6/7.","Renergen merger expected to close Q3 2025; all but one regulatory approval received.","ASPI listed on JSE on Aug 27, 2025; institutional ownership now over 70%.","Quantum Leap Energy targeting public listing Q4 2025; first Lithium-6 plant expected 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":968826999.8725638,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":144352,"accession_number":"0001477932-25-006215","cik":1921865,"company_name":"ASP Isotopes Inc.","ticker":"ASPI","form_type":"8-K","filed_at":"2025-08-25T23:59:59+00:00","items":["7.01"],"status":"ready","headline":"ASPI updates on isotope production; JSE listing set for Aug 27","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Silicon-28: commercial production began Mar 2025; first samples shipped to US customer in Aug 2025.","Ytterbium-176: enrichment factor 52; expects first batch enriched to 99.75% by late Aug 2025.","Received first permit for controlled laser equipment to enrich Nickel-64, Gadolinium-160, Zinc-68; accelerating facility construction.","Carbon-12 enrichment started to 99.99% for US customer; first commercial product expected Sep 2025 (delayed from Aug).","QLE spin-out anticipated H2 2025; Renergen acquisition expected to close Q3 2025; RedChip call Aug 28."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":968826999.8725638,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":144351,"accession_number":"0001477932-25-005962","cik":1921865,"company_name":"ASP Isotopes Inc.","ticker":"ASPI","form_type":"8-K","filed_at":"2025-08-15T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"ASPI and Quantum Leap Energy sign MOU with Fermi America for HALEU facility in Texas","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["MOU with Fermi America (co-founded by Rick Perry) for JV to build HALEU enrichment facility at planned 11GW HyperGrid Campus near Amarillo, TX.","ASPI plans separate 100%-owned stable isotopes facility at the campus for materials like Silicon-28 and Germanium-70 for quantum computing and nuclear medicine.","Site adjacent to Pantex plant, pre-qualified for nuclear deployment, leased from Texas Tech University System.","QLE expects spin-out as public company in 4Q25; has HALEU supply agreements with TerraPower for up to 150 metric tons through 2037.","Fermi America has submitted COL application for four Westinghouse AP1000 reactors; first reactor expected operational by 2032."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":968826999.8725638,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":144350,"accession_number":"0001477932-25-005585","cik":1921865,"company_name":"ASP Isotopes Inc.","ticker":"ASPI","form_type":"8-K","filed_at":"2025-08-08T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"ASP Isotopes expects JSE dual listing Aug 27; Renergen acquisition on track for Q3 2025","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["JSE dual listing expected to begin Aug 27, 2025; company retains Nasdaq primary listing.","Renergen acquisition approved by 99.8% of Renergen shareholders; expected close Q3 2025.","Combined company targets over $300M EBITDA by 2030 from isotopes, helium, and LNG.","Inducement awards: 400,000 restricted shares to EVP Donald Ainscow and 30,000 to new employee."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":968826999.8725638,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":144349,"accession_number":"0001477932-25-005317","cik":1921865,"company_name":"ASP Isotopes Inc.","ticker":"ASPI","form_type":"8-K","filed_at":"2025-07-30T23:59:59+00:00","items":["1.01","7.01","9.01"],"status":"ready","headline":"ASP Isotopes invests $5M in IsoBio for Series Seed-1 Preferred Stock","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["ASP Isotopes acquired 2M shares of IsoBio Series Seed-1 Preferred at $2.50/share for $5M total.","IsoBio is a radiotherapeutic developer focused on antibody-isotope conjugates (AICs) for cancer.","IsoBio was co-founded by Bruce Turner, M.D., PhD, former Roche executive and co-leader of Immunome merger.","ASP Isotopes gets one board seat (CEO Paul Mann), veto rights over major actions, and antidilution protection.","Related parties: CEO Paul Mann and director Todd Wider hold IsoBio stock; both are parties to voting and ROFR agreements."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":968826999.8725638,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":144348,"accession_number":"0001477932-25-005258","cik":1921865,"company_name":"ASP Isotopes Inc.","ticker":"ASPI","form_type":"8-K","filed_at":"2025-07-28T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"ASP Isotopes provides $5M seed funding to IsoBio for cancer radiotherapeutics","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["IsoBio closed initial Series Seed round, raising $5 million from ASP Isotopes (ASPI).","IsoBio will develop antibody-isotope conjugates (AICs) using Lutetium-177, Actinium-225, Terbium-161, and other novel isotopes.","IsoBio is co-founded and led by CEO Bruce Turner, M.D., Ph.D., former Immunome co-lead; offices in Seattle and Gladwyne, PA.","Strategic collaboration includes future manufacturing opportunities with ASPI's nuclear medicine subsidiary PET Labs.","Investor webcast to discuss collaboration on July 30, 2025 at 10:00 AM Eastern."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":968826999.8725638,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":144347,"accession_number":"0001477932-25-005246","cik":1921865,"company_name":"ASP Isotopes Inc.","ticker":"ASPI","form_type":"8-K","filed_at":"2025-07-25T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"ASP Isotopes receives conditional South African approval for Renergen acquisition","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Competition Commission approved as of July 23, 2025, subject to conditions acceptable to the Company.","Scheme effective in Q3 2025; final conditions must be fulfilled or waived by Sept 30, 2025.","Renergen is a South African producer of liquefied helium and LNG; combination targets $300M+ EBITDA by 2030.","Transaction expected to be highly accretive to ASPI's revenue, EBITDA, EPS, and cash flow from 2026.","Goal: create global leader in critical materials including isotopes, helium, and electronic gases."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":968826999.8725638,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":144346,"accession_number":"0001477932-25-005221","cik":1921865,"company_name":"ASP Isotopes Inc.","ticker":"ASPI","form_type":"8-K","filed_at":"2025-07-24T23:59:59+00:00","items":["1.01","1.02","8.01","9.01"],"status":"ready","headline":"ASP Isotopes prices $60M registered direct offering of 7.5M shares at $8.00/share","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Gross proceeds ~$60M; net ~$56.2M after underwriting discounts and expenses.","Offered 7.5M shares at $8.00/sh to a single fundamental institutional investor.","Cantor Fitzgerald and Canaccord Genuity acted as joint book-running managers.","Proceeds for general corporate purposes, including working capital and capex.","Closes on/around July 25, 2025; prior ATM equity agreement terminated with no shares sold."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":968826999.8725638,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":144345,"accession_number":"0001477932-25-005105","cik":1921865,"company_name":"ASP Isotopes Inc.","ticker":"ASPI","form_type":"8-K","filed_at":"2025-07-17T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"ASP Isotopes upgrades Silicon-28 capacity to >80 kg/yr; QLE spin-out targeted Oct 2025","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Silicon-28 capacity upgraded to >80 kg/yr (prior guidance >50 kg) with $4M investment; first shipments expected Aug 2025.","Ytterbium-176 enrichment factor 52; commercial samples expected to ship Aug 2025; transitioning to semi-continuous processing.","Carbon-12 enrichment using ASP technology; first commercial product expected Aug 2025; demand exceeds Carbon-14.","QLE spin-out targeted for Oct 2025; Renergen acquisition expected to close Q3 2025, subject to regulatory approvals.","Received first permits for laser equipment to enrich Nickel-64, Gadolinium-160, and Zinc-68 isotopes."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":968826999.8725638,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":144344,"accession_number":"0001477932-25-004983","cik":1921865,"company_name":"ASP Isotopes Inc.","ticker":"ASPI","form_type":"8-K","filed_at":"2025-07-11T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"ASP Isotopes acquisition of Renergen approved by 99.8% of Renergen shareholders","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Renergen shareholders voted 99.80% in favor of scheme of arrangement for acquisition by ASP Isotopes.","Transaction remains subject to regulatory approvals and third-party consents; expected effective Q3 2025.","Combined entity targets over $300M EBITDA by 2030 from isotopes, helium, and LNG sales.","Deal expected to be highly accretive to ASP Isotopes revenue, EBITDA, EPS, and cash flow from 2026.","Combination aims to create global leader in critical materials including helium and isotopically enriched gases."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":968826999.8725638,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":"2025-07-11T23:59:59+00:00|144344"}